From 12 to 14 December 2023, we continued to build excellence in the support services of the National Institute of Biology (NIB) when three colleagues from the corporate services (two from the project office and one from the institute library) travelled to Amsterdam, where they were hosted by the CutCancer project partner Amsterdam UMC (VUmc).…
Read article
Delegation from Swansea University, UK, visits the National Institute of Biology as part of the HEU CutCancer project From 14 to 16 November, the National Institute of Biology (NIB) hosted a delegation from Swansea University (the UK 5th university for collaborative research income per academic) as part of the HEU Twinning CutCancer project. The delegation…
Read article
The General Assembly meeting on 10 November 2023 brought together representatives from all project partners. The aim of the online meeting was to assess the collective progress made so far and to outline a roadmap for future collaborative initiatives. The event began with a welcome from the chair, prof. Bojana Žegura, National Institute of Biology.…
Read article
As the first year of the project implementation is coming to an end, the first Annual Project Meeting was held via Zoom on 10 November 2023 to review the work done so far and look ahead to the project’s future activities. Hosted by the National Institute of Biology, the meeting began with an overview of…
Read article
“If we don’t speak up, they will not hear!” We were very honoured and grateful to present our CutCancer Project and our research done at NIB (National Institute of Biology), at Research & Innovation Transforming European Healthcare in Brussels, that was so greatly organized by Slovenian Business & Research Association (SBRA) Prof. Dr. Drasko Veselinovic…
Read article
Tumours are complex mixture of a heterogeneous population of cells that possess distinct genetic, morphological, and phenotypic profiles, which can affect tumour development and therapeutic resistance. The success of cancer treatments relies on the comprehension of the heterogeneous and immune hostile tumour microenvironment (TME), further on providing additional possibilities to eliminate its tumour supportive role.…
Read article
Dr. Van Maldegem from VUmc is one of the pioneers in using and developing Imaging Mass Cytometry (IMC) method for cancer research. IMC enables detailed and contextual characterisation of protein expression and is a mass spectrometry-based technique that allows for the immunostaining of up to 40 markers in a single tissue section. Tissue sections of primary…
Read article
International Conference on Pathology of the Victor Babeș Institute took place at the the Institute, Splaiul Independeței 99-101, Bucharest, between November 2-4, 2022. The conference covered topis of cellular and molecular pathology, immunology, omics, neuroscience and cardiovascular pathology. Barbara Breznik has been invited to give a talk “Personalized tumor models reveal mechanisms of glioblastoma immunosuppressive…
Read article
We visited Karolinska Institutet and Lewensohn/Viktorsson team and their research facility on a sunny October day. Metka and Barbara presented CutCancer project and their research on “Personalized glioblastoma model for standard and immuno-therapy research” at translational lunch seminar that was open for researchers and medical doctors. Glioblastoma remains a lethal disease despite current standard treatment…
Read article